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Abstract: Three examples illustrate the versatility and usefulness of 
biothermodynamics.  The first example concerns calculation of a phase 
diagram for aqueous lysozyme with a new potential of mean force that 
takes the Hofmeister effect into account; such calculations may be useful 
for design of a separation process where addition of a salt to an aqueous 
protein mixture precipitates a target protein.  The second example 
concerns thermodynamic studies to elucidate the effect of an organic 
cosolvent on the mechanism of crystallizing aqueous insulin.  The final 
example concerns a thermodynamic contribution to mitigating the AIDS 
epidemic; it indicates how isothermal-titration-calorimetry studies are 
helpful for choosing an optimum inhibitor that is effective not only for 
the wild-type HIV protease but also for at least some of its mutants. 
INTRODUCTION 
The great virtue of thermodynamics is its generality, its wide range of potential applicability for 
describing a large variety of natural phenomena.  Regrettably, for historical reasons, the word 
“thermodynamics” is a misnomer; while the science of heat engines developed 150 years ago has 
been extended to numerous areas of physics and chemistry, the word “thermodynamics” has 
unfortunately not experienced a corresponding change.  In the chemical sciences, when we talk 
about thermodynamics today, we rarely refer to heat engines.  We refer, instead, to a quantitative 
description of nature but, nevertheless, we retain the word “thermodynamics” because we continue 
to use the general mathematical framework that was established by the thermodynamics pioneers 
of the nineteenth century. 
In the eighteen seventies, when Gibbs showed how the framework of thermodynamics can be 
used for describing equilibria in physical chemistry, did he realize that his remarkable work could 
also be used for applications in biology?  We don’t know.  But it is likely that if Gibbs could see 
the dramatically increasing literature on biothermodynamics, he would be pleased but not 
surprised. 
This article presents three examples in recent biothermodynamics as discussed in the literature.  
They are: 
1.  Calculation of the phase diagram for an aqueous target protein in a separation process where 
addition of a salt causes protein precipitation (Tavares et al). 
2.  Effect of an organic co-solvent on the crystallization of aqueous insulin (Vekilov et al). 
3.  Design of a versatile inhibitor to prevent in-vivo reproduction of the HIV virus and its 
mutants (Ohtaka and Freire). 
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The first example concerns a classical phase-equilibrium calculation within the McMillan-
Mayer framework.  These calculations use a new potential of mean force to describe protein-
protein interactions in an aqueous medium that also contains a salt.  This new potential includes 
the Hofmeister effect.   
The second example uses the thermodynamics of crystallization to interpret crystallization data; 
this interpretation provides information on how an organic co-solvent significantly increases the 
rate of crystallization of insulin from an aqueous solution. 
The third example shows how experimental enthalpy and entropy data for binding the HIV 
protease help to guide development of a versatile drug for treating patients with AIDS. 
Phase Equilibria for an Aqueous Protein 
In biotechnology, initial separation of a target protein from a bioreactor broth is often achieved 
by adding a salt to induce precipitation.  To provide guidance for attaining the desired separation, 
we require a pertinent phase diagram, i.e. a plot of temperature versus protein concentration or its 
equivalent, protein density in the solution, designated by ρ.  A common way to express protein 
density is provided by the protein packing fraction designated by 3
6 p
ρσπη =  where σp is the 
protein diameter. 
For fluid-solid equilibria, the essential equations of equilibrium are  
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where μF is the chemical potential of the protein in the fluid phase and μS is the chemical 
potential of the protein in the solid phase.  T is the temperature and p is the pressure.  Similar 
equations hold for fluid-fluid equilibria.   
At constant temperature, pressure p and chemical potential μ are related to ρ by well-known 
thermodynamics; both are derived from an expression for Helmholtz energy A as a function of ρ 
(or η), as discussed in numerous textbooks. 
We calculate AF and AS using the first-order Barker-Henderson perturbation theory, one for the 
fluid phase and another for the solid phase, as discussed, for example, by Tavares et al (1, 2).  For 
each phase, the chemical potential is obtained from two contributions, a hard-sphere (hs) term and 
a perturbation term (P): μ = μhs + μP    
For the fluid phase, μhs is obtained from the Carnahan-Starling equation of state.  For the solid 
phase, μhs is obtained from the equation of state proposed by Velasco. 
To calculate μP, we need an expression that provides information on the protein-protein 
interaction in the aqueous solution and in the precipitate.  That expression is the potential of mean 
force W(r) where r is the center-to-center distance between two quasi-spherical protein particles.  
This potential of mean force contains three contributions: 
 
W(r) = W(r)hs + W(r)el + W(r)att  (3) 
 
where el refers to electrostatic forces and att refers to attractive (dispersion) forces. 
Whs depends on the reduced distance r/σp. 
Wel depends on r/σp, σs, qp, qs, D and T where σs is the salt diameter, qp is the protein charge, qs 
is the salt charge and D is the dielectric constant of water.   
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Watt depends on r/σp, H and on a new expression φ(ions).  Here, H is the Hamaker constant that 
reflects the dispersion (van der Waals) forces between the aqueous protein particles, neglecting the 
effect of the salt ions.  φ(ions) provides the contribution to protein-protein attractive forces due to 
dispersion forces arising from van der Waals interactions between the ions and between the ions 
and the protein.  It is this function, φ(ions), that is responsible for the well-known Hofmeister 
effect.  While this effect was discovered empirically more than 100 years ago, its quantitative 
(theoretical) formulation was derived only recently by Ninham and coworkers (3), and by Tavares 
et al (4).  The function φ(ion) depends on the aqueous polarizabilities of the protein and the salt 
ions. 
Figure 1 shows three calculated phase diagrams for lysozyme (5).  Each diagram is for an 
aqueous lysozyme solution containing a sodium salt with concentration 0.2 M. 
Figure 1 shows the important effect of the salt’s anion.  NaCl and NaI show qualitatively 
similar behavior; we see a fluid-fluid region with an upper critical point on the left side and a 
fluid-solid region on the right.  However, the critical temperature for NaI is appreciably higher 
than that for NaCl. 
For NaSCN, we obtain a phase diagram that is qualitatively different from those for NaCl and 
NaI.  For NaSCN, we do not have a stable fluid-fluid region; only fluid-solid equilibria are 
thermodynamically stable.  There is no upper critical point.  However, in addition to fluid-solid 
equilibria, we also calculate metastable fluid-fluid equilibria, consistent with experiment.  The 
calculations show a region (dashed line) where μF' = μF'' where ´ refers to the dilute aqueous 
lysozyme solution and ˝ refers to the concentrated aqueous lysozyme solution.   
For solutions containing NaCl or NaI, fluid-fluid equilibria are stable.  However, for lysozyme 
solutions containing NaSCN, μF' and μF'' are larger than the corresponding μs at the same 
temperature.  For this case, the calculated (and observed) fluid-fluid equilibria are metastable. 
Because the polarizability of the SCN anion is larger than those for chloride and iodide anions, 
SCN anions adsorb more to the positively charged lysozyme, reducing the repulsive forces 
between lysozyme particles.  Thus, for lysozyme, NaSCN is a more effective precipitating salt 
than NaCl or NaI.   
Thermodynamics of Insulin Crystallization  
In the pancreas, insulin is stored in rhombohedral crystals.  In vivo, organic molecules, soluble 
in water, affect the crystallization of insulin.  Thermodynamics provides a useful tool toward a 
better understanding of the crystallization process. 
Vekilov and coworkers (6, 7) have measured in-vitro kinetics and equilibria for crystallization 
of aqueous insulin.  They found that addition of an organic cosolvent (acetone) to the aqueous 
solution dramatically increases the rate of crystallization by nearly one order of magnitude. 
These studies are of interest not only because they may help to develop a better therapy for 
diabetes but also because fundamental studies on crystallization of biomacromolecules may be 
useful for pharmacology; crystalline pharmaceuticals are often preferred over amorphous forms 
because crystalline pharmaceuticals have a slower and more controlled rate of dissolution. 
Consider a saturated solution of insulin in water in equilibrium with crystalline insulin.  
Vekilov and coworkers measured the (small) aqueous equilibrium concentration of insulin 
designated by ce. 
The standard Gibbs energy of crystallization is  
 
ΔG° = RTln(ce/c°) (4) 
 
where c° is the standard-state concentration (1 mol/kg solvent). 
Further, ΔG° = ΔH° - TΔS°. 
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From well-known thermodynamics,  
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Vekilov and coworkers measured ce as a function of temperature from 5 to 30 degrees Celsius.  
To obtain information on the effect of a representative organic cosolvent, Vekilov et al also 
measured ce as a function of acetone concentration.  Figure 2 shows results.  We see a 
discontinuity when the acetone concentration is near 12 volume percent. 
Because a crystal is more ordered than a liquid, we expect the entropy of crystallization to be 
negative.  However, in the absence of acetone, the observed entropy of crystallization is positive.  
By contrast, with acetone, the observed entropy of crystallization is negative.  Vekilov et al 
conclude that in aqueous solution, hydrophobic insulin is surrounded by a shell of adsorbed 
oriented water molecules; upon crystallization, these water molecules are released.  Because the 
released water molecules gain vibrational, translational and rotational degrees of freedom, the 
observed entropy of crystallization is positive. 
For good crystallization, a positive entropy charge is favorable, as observed for insulin 
crystallization from acetone-free water.  In the presence of acetone, the observed entropy charge is 
negative.  Nevertheless, with acetone, good crystallization is obtained because the desired negative 
change in enthalpy is more negative than that when insulin is crystallized from acetone-free water.   
When the concentration of acetone exceeds about 12 volume percent, the measured rate of 
crystallization is about seven times larger than that at lower acetone concentrations.  The 
mechanism of insulin crystallization from water requires removal of adsorbed water from the 
hydrated insulin molecule.  However, as suggested by the observed entropy of crystallization, at a 
sufficiently large acetone concentration, such removal is not necessary; because acetone prevents 
the formation of a shell of adsorbed water molecules, the rate of crystallization increases. 
Thermodynamic interpretation of the experimental thermodynamic results shows that the 
mechanism of insulin crystallization is significantly affected by the presence of an organic 
cosolvent like acetone.  Thermodynamic interpretation suggests that the organic co-solvent 
prevents hydration of the insulin molecule. 
This example shows that when experimental solubility data are subjected to thermodynamic 
analysis, we can obtain insight toward a molecular interpretation of crystallization of a 
biomacromolecule.  Such insight may contribute to improved processing of pharmaceuticals and, 
perhaps, to development of improved therapy for diabetes.  While thermodynamics alone is not 
sufficient, it can contribute toward progress in pharmacology.   
Thermodynamics for Drug Development 
Much continuing effort has been directed toward finding drugs to reduce the AIDS  epidemic 
caused by HIV.  Thermodynamics makes a contribution to that effort through thermodynamic 
interpretation of experimental calorimetric-titration data. 
As shown in Figure 3, after HIV infects a human cell, a series of steps produces replication of 
HIV.  The infected cell expresses a polyprotein and an HIV protease; the role of the protease is to 
cleave the polyprotein.  The cleaved proteins assemble to form a new HIV virus.   
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An effective strategy to prevent formation of a new virus is provided by introducing a drug that 
deactivates the HIV protease.  This drug, called a protease inhibitor, prevents cleavage of the 
polyprotein, as indicated in Figure 4.   
Deactivation of a protease inhibitor can be described by a traditional lock-and-key mechanism 
indicated in Figure 5.  The inhibitor must have the correct geometric shape to fit into the active 
site of the HIV protease; here the inhibitor is the “key” that must fit into the protease “lock”.   
However, because of mutations, the active site of an HIV protease can exist in a variety of 
forms, as shown schematically in Figure 5.  In this schematic illustration, the shape of the active 
site of the wild-type (the lock) is represented by a cross; for the mutant, the shape of the lock is 
represented by a hexagon.  We seek an inhibitor (the key) that is sufficiently flexible such that it 
“fits” into both types of “lock”.  We need a drug (the key) that can bind not only with the active 
site of the wild type protease but also with that of its mutant.  Thermodynamics can help to find 
the best drug candidates. 
To illustrate, Figure 6 shows two possible drug candidates, (1) and (2).  Drug (2) has better 
adaptability than drug (1) because, compared to drug (1), it has asymmetric functionality: the 
toluene group has less symmetry than the tertiary butyl group, as indicated by oval circles.  More 
important, drug (2) is more flexible because it has two rotating bonds while drug (1) has only one, 
as indicated by dashed arrows.  Asymmetry and flexibility provide the drug with additional 
conformations that can adapt to a mutant HIV binding site.   
Toward obtaining a quantitative measure of drug efficacy, we can use results from isothermal 
titration calorimetry (ITC) reported by Ohtaka and Freire (8).   
Let A stand for the HIV protease and B for the inhibitor.  We define a dissociation constant Kd 
and its reciprocal, association constant Ka, where subscript a stands for association and subscript d 
for dissociation. 
 
][
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where [   ] stands for concentration.  For good drug efficacy, we want Kd to be small or, 
equivalently, Ka to be large. 
The binding of A (protease) and B (inhibitor) is determined by enthalpy ΔH° and entropy ΔS° 
through the thermodynamic relation 
 
-RTlnKa = ΔG°  = ΔH° - TΔS° (7) 
 
where superscript ° indicates a standard state. 
ITC provides experimental data for measuring Kd (or Ka), ΔG°, ΔH° and ΔS°. 
Figure 7 shows experimental results for ΔG°, ΔH°, and -TΔS° for twelve drug candidates 
where the protease is the wild form. 
As indicated in Eq(7), for a successful drug, we want ΔG° to be large and negative.  We can 
achieve a large negative ΔG° by either a large and negative ΔH° or else by a large and negative -
TΔS° or both. 
If ΔG° is large and negative, the extent of binding is large; that’s good.  But we also want ΔH° 
to be large and negative because, in that case, we increase the strength of interaction of inhibitor 
(B) with protease (A).   
In Figure 7, the first generation of drugs contains molecules that are relatively rigid (not 
flexible).  Within the active-site pocket of the protease, rigid molecules cannot interact strongly 
with the functional groups of the protease and therefore, for these drugs, ΔH° is not favorable; in 
some cases, while negative, the absolute value is small and in other cases, most unfavorable, ΔH° 
is positive.  However, -TΔS° is favorable because upon binding, the hydrophobic drug releases 
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hydrated water molecules with a subsequent desirable gain in entropy. 
Because rigid drug molecules do not have as much adaptability to mutant proteases as flexible 
molecules, second generation inhibitors contain relatively flexible drugs.  As shown in Figure 7, 
these drugs show a favorable ΔH° but -TΔS° is now less favorable because of what is called the 
entropic penalty.  When a flexible “key” enters a confining “lock”, it loses not only translational 
degrees of freedom (as does a rigid “key”) but, in addition, it loses rotational degrees of freedom.  
These losses in freedom produce a decrease in entropy; because this decrease is unfavorable, 
flexible drugs exhibit a greater entropic penalty (smaller |-TΔS°|) than rigid drugs.  However, the 
tradeoff for this entropic penalty is a more favorable binding interaction, i.e. a large and negative 
ΔH°.  Figure 7 suggests that drugs 11 and 12 are best since ΔH° and ΔG° are both large and 
negative; the inhibitors are adaptive, the benefits of which we will see in a moment.   
Because protease mutations are common, we seek an inhibitor that is effective not only for the 
wild-type protease but, in addition, adaptive to some of its mutants. 
Figure 8 shows ITC results for a series of inhibitors interacting with the wild type (WT) and 
with a particular mutant (M).  The ordinate, on a logarithmic scale, shows the dissociation 
constant Kd; we want Kd to be small not only for the wild type but also for the mutant. 
Figure 8 shows the importance of having a large, negative ΔH°.  The more adaptive second 
generation drugs, for example inhibitors 11 and 12, have the smallest dissociation constant for 
both the wild type and for the mutant HIV protease.  In Figure 7, results for the wild type indicate 
that inhibitors 11 and 12 are best because they have two desirable features:  both ΔG° and ΔH° are 
negative and large.  However, Figure 8 shows that, while inhibitors 11 and 12 are good for the 
wild-type protease, inhibitor 11 is superior for inhibiting the mutant protease.  Figure 8 suggests 
that drug 11 is better than drug 12.    
We want ΔG° and ΔH° to be large and negative.  We achieve large and negative ΔH°  with a 
flexible inhibitor.  Further, we prefer a flexible inhibitor because, unlike a rigid inhibitor, it has a 
better chance to be effective not only for the wild-type protease but also for a mutant.  However, 
for a flexible inhibitor we must pay the price of an entropic penalty; this penalty is undesirable 
because it lowers the absolute value of a negative ΔG°.  In other words, we want an inhibitor that 
is flexible enough to give a large negative ΔH° and that is flexible enough to be useful for a 
protease mutant.  However, the inhibitor should not be too flexible lest the entropic penalty 
become too large.  Thermodynamic studies are useful for guidance toward designing the optimum 
inhibitor. 
Conclusion 
The examples shown here illustrate the utility of chemical thermodynamics.  In each example, 
thermodynamics provides a theoretical framework for contributing toward obtaining an answer to 
a problem in biotechnology.  Coupled with insights from molecular physics and with suitable 
experimental data, this framework can lead to useful results. 
The generality and versatility of thermodynamics allows application to all materials, no matter 
how complex.  We must not be afraid of biomacromolecules like proteins; they too are subject to 
the laws of thermodynamics.   
More than 80 years ago, Gilbert Lewis and Merle Randall published a pioneering book 
(Thermodynamics and the Free Energy of Substances) that showed how the abstract chemical 
thermodynamics of Gibbs can be applied to real solids and fluids.  Once again we are inspired by 
the book’s first page:   
 
Let this book be dedicated to the chemists of the newer generation, who will not wish to reject 
all inferences from conjecture or surmise, but who will not care to speculate concerning that 
which may be surely known.  The fascination of a growing science lies in the work of the 
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pioneers at the very borderland of the unknown, but to reach this frontier one must pass over 
well-traveled roads; of these one of the safest and surest is the broad highway of 
thermodynamics.   
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